Barrett's esophagus and esophageal adenocarcinoma are common after treatment for achalasia

Digestive Diseases and Sciences

Volumn 58, Issue 1, 2013, Pages 244-252

  Leeuwenburgh, I ^a   Scholten, P ^a   Calje T J ^a   Vaessen, R J ^a   Tilanus, H W ^a   Hansen, B E ^a   Kuipers, E J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Achalasia; Barrett's esophagus; Esophageal adenocarcinoma; Hiatus hernia; Surveillance

Indexed keywords

ANTACID AGENT; BARIUM; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BALLOON DILATATION; BARIUM MEAL; BARRETT ESOPHAGUS; CANCER RISK; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGRAPHY; ESOPHAGOSCOPY; ESOPHAGUS ACHALASIA; ESOPHAGUS MANOMETRY; FEMALE; FOLLOW UP; HIATUS HERNIA; HUMAN; HUMAN TISSUE; INCIDENCE; LOWER ESOPHAGUS SPHINCTER PRESSURE; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; SCHOOL CHILD;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ESOPHAGEAL ACHALASIA; ESOPHAGEAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS; TREATMENT OUTCOME;

EID: 84873108053     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2157-9     Document Type: Article

References (39)

1. Mayberry JF. Epidemiology and demographics of achalasia. Gastrointest Endosc Clin North Am. 2001;11:235-248, v.
2. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ. Increasing incidence of Barrett's oesophagus in the general population. Gut. 2005;54:1062-1066.
3. Cameron AJ, Lomboy CT. Barrett's esophagus: age, prevalence, and extent of columnar epithelium. Gastroenterology. 1992;103:1241-1245.
4. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.
5. van Blankenstein M, Looman CW, Johnston BJ, Caygill CP. Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol. 2005;100:568-576.
6. de Jonge PJ, van Blankenstein M, Looman CW, Casparie MK, Meijer GA, Kuipers EJ. Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study. Gut. 2010;59:1030-1036.
7. Kauer WK, Stein HJ. Role of acid and bile in the genesis of Barrett's esophagus. Chest Surg Clin N Am. 2002;12:39-45.
8. Schoeman MN, Tippett MD, Akkermans LM, Dent J, Holloway RH. Mechanisms of gastroesophageal reflux in ambulant healthy human subjects. Gastroenterology. 1995;108:83-91.
9. Walzer N, Hirano I. Achalasia. Gastroenterol Clin North Am. 2008;37:807-825, viii.
10. Alderliesten J, Conchillo JM, Leeuwenburgh I, Steyerberg EW, Kuipers EJ. Predictors for outcome of failure of balloon dilatation in patients with achalasia. Gut. 2011;60:10-16.
11. Reynolds JC, Parkman HP. Achalasia. Gastroenterol Clin North Am. 1989;18:223-255.
12. Leeuwenburgh I, Van Dekken H, Scholten P, et al. Oesophagitis is common in patients with achalasia after pneumatic dilatation. Aliment Pharmacol Ther. 2006;23:1197-1203.
13. Ellis FH Jr, Gibb SP, Balogh K, Schwaber JR. Esophageal achalasia and adenocarcinoma in Barrett's esophagus: a report of two cases and a review of the literature. Dis Esophagus. 1997;10:55-60.
14. Guo JP, Gilman PB, Thomas RM, Fisher RS, Parkman HP. Barrett's esophagus and achalasia. J Clin Gastroenterol. 2002;34:439-443.
15. Csendes A, Braghetto I, Burdiles P, Korn O, Csendes P, Henriquez A. Very late results of esophagomyotomy for patients with achalasia: clinical, endoscopic, histologic, manometric, and acid reflux studies in 67 patients for a mean follow-up of 190 months. Ann Surg. 2006;243:196-203.
16. Cantu P, Savojardo D, Baldoli D, Bonavina L, Penagini R. Barrett's esophagus in untreated achalasia: 'guess who's coming to dinner' first. Dis Esophagus. 2008;21:473.
17. Sikkema M, de Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235-244; quiz e232.
18. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology. 2000;119:333-338.
19. Boeckxstaens GE, Annese V, des Varannes SB, et al. Pneumatic dilation versus laparoscopic Heller's myotomy for idiopathic achalasia. N Engl J Med. 2011;364:1807-1816.
20. Burke CA, Achkar E, Falk GW. Effect of pneumatic dilation on gastroesophageal reflux in achalasia. Dig Dis Sci. 1997;42:998-1002.
21. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology. 2002;123:461-467.
22. Prach AT, MacDonald TA, Hopwood DA, Johnston DA. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet. 1997;350:933.
23. Locke GR 3rd, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ 3rd. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112:1448-1456.
24. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Long-term omeprazole treatment in resistant gastroesophageal reflux disease: efficacy, safety, and influence on gastric mucosa. Gastroenterology. 2000;118:661-669.
25. Spiess AE, Kahrilas PJ. Treating achalasia: from whalebone to laparoscope. JAMA. 1998;280:638-642.
26. Kuipers EJ. Barrett's oesophagus, proton pump inhibitors and gastrin: the fog is clearing. Gut. 2010;59:148-149.
27. van Herwaarden MA, Samsom M, Smout AJ. Prolonged manometric recordings of oesophagus and lower oesophageal sphincter in achalasia patients. Gut. 2001;49:813-821.
28. Benini L, Sembenini C, Castellani G, et al. Pathological esophageal acidification and pneumatic dilitation in achalasic patients. Too much or not enough? Dig Dis Sci. 1996;41:365-371.
29. Crookes PF, Corkill S, DeMeester TR. Gastroesophageal reflux in achalasia. When is reflux really reflux? Dig Dis Sci. 1997;42:1354-1361.
30. Stamp DH. Three hypotheses linking bile to carcinogenesis in the gastrointestinal tract: certain bile salts have properties that may be used to complement chemotherapy. Med Hypotheses. 2002;59:398-405.
31. Orlando RC. Overview of the mechanisms of gastroesophageal reflux. Am J Med. 2001;111:174S-177S.
32. Ott DJ, Gelfand DW, Chen YM, Wu WC, Munitz HA. Predictive relationship of hiatal hernia to reflux esophagitis. Gastrointest Radiol. 1985;10:317-320.
33. Ott DJ, Hodge RG, Chen MY, Wu WC, Gelfand DW. Achalasia associated with hiatal hernia: prevalence and potential implications. Abdom Imaging. 1993;18:7-9.
34. Binder HJ, Clemett AR, Thayer WR, Spiro HM. Rarity of hiatus hernia in achalasia. N Engl J Med. 1965;272:680-682.
35. Olsen AM, Holman CB, Andersen HA. The diagnosis of cardiospasm. Dis Chest. 1953;23:477-498.
36. Taub W, Achkar E. Hiatal hernia in patients with achalasia. Am J Gastroenterol. 1987;82:1256-1258.
37. Goldenberg SP, Vos C, Burrell M, Traube M. Achalasia and hiatal hernia. Dig Dis Sci. 1992;37:528-531.
38. Kahrilas PJ, Kim HC, Pandolfino JE. Approaches to the diagnosis and grading of hiatal hernia. Best Pract Res Clin Gastroenterol. 2008;22:601-616.
39. Hyun JJ, Bak YT. Clinical significance of hiatal hernia. Gut Liver. 2011;5:267-277.